Squarylated lactones inhibitors for bacterial biofilm formation
AssigneeSyracuse University
InventorsYan-Yeung Luk, Sri Kamesh Narasimhan, Eric Falcone
Life of this patent
Estimating the term…
Abstract
A library of unnatural squarylated homoserine lactones (SHLs) and squarylated lactones that bear potential to modulate biofilm formation in Gram negative bacteria. At low concentrations (˜200 μM), these small molecules inhibit biofilm formation of E. coli. Moreover, these compounds are not toxic up to 300 μM and do not significantly attenuate E. coli growth. The SHLs have potential to disperse established biofilm and demonstrate an enhanced reduction (˜50%) of the maximum biofilm thickness by use of SHLs during biofilm growth.
Claims7
A squarylated homoserine lactone, comprising the structure:
- wherein R is a group selected from the group consisting of methyl, ethyl, n-butyl, n-hexyl, phenyl, tolyl, and thienyl.
A squarylated homoserine lactone, wherein said structure is selected from the group consisting of
A squarylated homoserine lactone, comprising the structure:
- wherein R is a group selected from the group consisting of methyl, ethyl, n-butyl, n-hexyl, phenyl, tolyl, and thienyl.
Dependencies are inferred from the claim text.